This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Tohoku University, Nagasaki University. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013-2015
Title: Koji Nishida: Innovator in Drug Delivery Systems
Introduction
Koji Nishida is a prominent inventor based in Miyagi, Japan. He has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. His innovative approaches aim to enhance the efficacy and safety of drug administration.
Latest Patents
Nishida's latest patents focus on a sustained drug delivery system. This system is designed to deliver a drug at a sustained constant rate over an extended period. It can be safely transplanted into the affected area in a simple manner, ensuring that the drug reaches the target site effectively. Specifically, the sustained drug delivery system involves an implant that is inserted into the body. The implant consists of a PEG capsule, which includes a box-shaped PEG and a porous PEG sheet. This innovative design allows for prolonged drug delivery, addressing the needs of patients requiring long-term treatment.
Career Highlights
Throughout his career, Koji Nishida has worked with esteemed institutions such as Tohoku University and Nagasaki University. His research and development efforts have significantly advanced the field of drug delivery, making him a respected figure among his peers.
Collaborations
Nishida has collaborated with notable colleagues, including Hirokazu Kaji and Matsuhiko Nishizawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Koji Nishida's work in developing sustained drug delivery systems showcases his commitment to improving patient care through innovative solutions. His contributions to the field are invaluable and continue to influence future advancements in drug delivery technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile